drugset / Trial / NCT00687011
Palonosetron Plus Dexamethasone in Moderately Emetogenic Chemotherapy Induced Nausea and Vomiting (Study P04594)
NaSingle-groupOpen-labelPrevention
Summary
The purpose of this study is to determine if a single intravenous (IV) dose of palonosetron 0.25 mg plus a single IV dose of dexamethasone 8 mg is effective to prevent nausea and vomiting induced by moderately emetogenic chemotherapy in subjects with cancer.
Timeline
- Start
- 2006-10-10
- Primary completion
- 2008-10-27
- Completion
- 2008-10-27
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Dexamethasone | Small molecule | 8 mg | Intravenous |
| Subject | Dexamethasone | Small molecule | 20 mg | Intravenous |
| Subject | Palonosetron | Other / unclassified | 0.25 mg | Intravenous |
| Background | Methylprednisolone | Other / unclassified | 125 mg | Intravenous |